Skip to content
PubMed This is a summary of 61 peer-reviewed journal articles Updated
Reproductive Endocrinology

Validating Your Journey: An Orientation to Asherman Syndrome

At a Glance

Asherman syndrome is a condition involving scar tissue in the uterus, but it is highly treatable. With expert hysteroscopic surgery, about 95% of patients achieve a healthy, open uterine cavity, and many go on to have successful pregnancies.

Receiving a diagnosis of Asherman syndrome can feel like a secondary trauma, especially when it follows a difficult medical event like a miscarriage or a postpartum complication [1]. It is a condition where scar tissue, clinically known as intrauterine adhesions (IUA), forms inside the uterus, often causing the walls to stick together [2]. While it is a physical condition, the emotional weight of infertility or pregnancy loss can be significant [1]. Understanding the facts and securing the right medical expertise are the first steps toward healing.

Stabilizing Facts

When you are first diagnosed, it is easy to feel overwhelmed by the unknown. However, several key findings in recent research provide a perspective that can help you plan your next steps:

  1. High Success in Uterine Restoration: Modern surgical techniques are highly effective at physically opening the uterine cavity. About 95% of patients achieve a healthy, open uterine cavity within one to three surgical attempts [2].
  2. Pregnancy is Possible: Many patients who desire a family go on to have successful pregnancies after treatment. While overall live birth rates across all severity levels hover around 41% [3], success rates for those with mild-to-moderate scarring who actively try to conceive are significantly higher. Some patients achieve live birth rates comparable to those undergoing IVF for other reasons [4].
  3. Severity Does Not Equal Fate: Even if your case is classified as “severe,” research shows that the initial severity of the scar tissue does not always predict your final chance of a live birth [5][6]. There are also alternative paths to parenthood, which are discussed in our Survivorship section.

Why a Specialist Matters

Asherman syndrome is a rare and complex condition that is often outside the daily practice of a general OBGYN. Seeking a hysteroscopic specialist—often a Reproductive Endocrinologist (REI) or a surgeon specializing in minimally invasive gynecologic surgery—is critical for several reasons:

  • Precision Surgery: Specialized surgeons use a hysteroscope (a thin, lighted camera inserted through the cervix) to carefully remove scar tissue without damaging the healthy lining (endometrium) [2][7].
  • Preventing Recurrence: Scar tissue has a tendency to grow back, occurring in about 28.7% of cases [2]. Specialists use advanced tools like physical barriers (intrauterine balloons or stents) and specialized gels to keep the uterine walls separated while they heal [8][9].
  • Expert Follow-up: Specialized care includes a “second-look” procedure shortly after the initial surgery to catch and remove any tiny new adhesions before they become a larger problem [10][11].

Navigating the Uncertainties

While medical science has advanced significantly, some aspects of Asherman syndrome are still being debated by experts. You may hear different opinions on:

  • Hormone Therapy: Many doctors prescribe estrogen after surgery to help the uterine lining regrow, but there is no universal agreement on the exact dose or how long it should be taken [1][12].
  • The Best Barrier: While experts agree that some type of barrier is needed to prevent new scars, they are still researching whether balloons, gels, or a combination of both works best [13][14].
  • Pregnancy Risks: Once you become pregnant after treatment, you are at a higher risk for certain placental issues, such as placenta accreta (where the placenta attaches too deeply). Because of this, your pregnancy will likely require monitoring by a high-risk obstetrician [15][16].

Common questions in this guide

Can I still get pregnant if I have Asherman syndrome?
Yes, many patients go on to have successful pregnancies after treatment. While overall live birth rates are around 41%, success rates are significantly higher for those with mild-to-moderate scarring who actively try to conceive.
How is Asherman syndrome treated?
The primary treatment is specialized minimally invasive surgery. A specialist uses a hysteroscope to carefully remove scar tissue without damaging the healthy uterine lining.
Will the scar tissue return after surgery?
Scar tissue grows back in about 28.7% of cases. To prevent this, specialists often use physical barriers like intrauterine balloons or specialized gels to keep the uterine walls separated while they heal.
What kind of doctor treats Asherman syndrome?
It is highly recommended to see a hysteroscopic specialist, such as a Reproductive Endocrinologist (REI) or a surgeon specializing in minimally invasive gynecologic surgery. They have the precise skills and tools needed to treat this complex condition safely.
Does severe Asherman syndrome mean I cannot have a baby?
Not necessarily. Research indicates that the initial severity of uterine scar tissue does not always predict your final chance of a live birth. With modern surgical techniques, even severe cases can often be treated effectively.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many hysteroscopic adhesiolysis procedures for Asherman syndrome do you perform each year?
  2. 2.What specific methods do you use during and after surgery to prevent adhesions from growing back?
  3. 3.What is your plan for a 'second-look' hysteroscopy to ensure the cavity stays open?
  4. 4.Do you work with a high-risk pregnancy specialist (maternal-fetal medicine) for follow-up care?
  5. 5.Based on my imaging, how would you grade the severity of my adhesions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Secondary Prevention of Intrauterine Adhesions Following Hysteroscopic Surgery in Women With Asherman Syndrome: Is Something Better Than Nothing?

    Kelley AS, Giuliani E, Schon SB

    Clinical obstetrics and gynecology 2020; (63(2)):320-326 doi:10.1097/GRF.0000000000000510.

    PMID: 31815774
  2. 2

    Results of centralized Asherman surgery, 2003-2013.

    Hanstede MM, van der Meij E, Goedemans L, Emanuel MH

    Fertility and sterility 2015; (104(6)):1561-8.e1.

    PMID: 26428306
  3. 3

    A retrospective cohort study to examine factors affecting live birth after hysteroscopic treatment of intrauterine adhesions.

    Zhao Y, Huang X, Huang R, et al.

    Fertility and sterility 2024; (121(5)):873-880 doi:10.1016/j.fertnstert.2024.01.022.

    PMID: 38246404
  4. 4

    Treatment of intrauterine adhesions and subsequent pregnancy outcomes in an in vitro fertilization population.

    Mortimer RM, Lanes A, Srouji SS, et al.

    American journal of obstetrics and gynecology 2024; (231(5)):536.e1-536.e10 doi:10.1016/j.ajog.2024.05.026.

    PMID: 38777163
  5. 5

    Patient-reported menstrual and obstetric outcomes following hysteroscopic adhesiolysis for Asherman syndrome.

    Morales B, Movilla P, Wang J, et al.

    F&S reports 2021; (2(1)):118-125 doi:10.1016/j.xfre.2021.01.002.

    PMID: 34223282
  6. 6

    Hysteroscopic adhesiolysis: efficacy and safety.

    Sanad AS, Aboulfotouh ME

    Archives of gynecology and obstetrics 2016; (294(2)):411-6 doi:10.1007/s00404-016-4107-9.

    PMID: 27129970
  7. 7

    Comparison of hysteroscopic adhesiolysis with electrosurgery instrument or hysteroscopic scissors in the treatment of intrauterine adhesions of infertile or recurrent pregnancy loss women.

    Li Y, Li Y, Wang Y, et al.

    Archives of gynecology and obstetrics 2025; (311(4)):1063-1071 doi:10.1007/s00404-024-07866-8.

    PMID: 39673604
  8. 8

    Extended intrauterine balloon stent use to prevent adhesion reformation after hysteroscopic adhesiolysis: a randomized trial.

    Luo Y, Liu Y, Xiao Y, et al.

    Fertility and sterility 2025; (124(1)):144-152 doi:10.1016/j.fertnstert.2025.01.024.

    PMID: 39884334
  9. 9

    Long-term effects of hysteroscopic adhesiolysis on postoperative pregnancy rates and fertility outcomes in patients with intrauterine adhesions.

    Hu Y, Ma Y, Li W, Qu J

    American journal of translational research 2024; (16(10)):5605-5613 doi:10.62347/GRAK9062.

    PMID: 39544752
  10. 10

    Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions.

    Sebbag L, Even M, Fay S, et al.

    Frontiers in surgery 2019; (6()):50 doi:10.3389/fsurg.2019.00050.

    PMID: 31475154
  11. 11

    Optimal timing of hysteroscopic follow-up to prevent the recurrence of intrauterine adhesions: a retrospective study.

    Dao S, Zhang L, Liu C, et al.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2025; (45(1)):2500970 doi:10.1080/01443615.2025.2500970.

    PMID: 40455065
  12. 12

    A randomized clinical trial of surgical intervention with or without acupuncture combined with traditional Chinese medicine to treat intrauterine adhesions.

    Wenwen Z, Jiaqi W, Jing S, et al.

    Contemporary clinical trials communications 2025; (48()):101565 doi:10.1016/j.conctc.2025.101565.

    PMID: 41230015
  13. 13

    Adjuvants to prevent reformation of adhesions following adhesiolysis for Asherman syndrome: a systematic review and meta-analysis.

    Guo J, Shi X, Yu F, et al.

    Human fertility (Cambridge, England) 2023; (26(4)):797-814 doi:10.1080/14647273.2023.2254492.

    PMID: 37778374
  14. 14

    Effectiveness of Hyaluronic Acid Gel and Intrauterine Devices in Prevention of Intrauterine Adhesions after Hysteroscopic Adhesiolysis in Infertile Women.

    Trinh TT, Nguyen KD, Pham HV, et al.

    Journal of minimally invasive gynecology 2022; (29(2)):284-290 doi:10.1016/j.jmig.2021.08.010.

    PMID: 34433103
  15. 15

    The incidence of placenta related disease after the hysteroscopic adhesiolysis in patients with intrauterine adhesions.

    Zhang LP, Wang M, Shang X, et al.

    Taiwanese journal of obstetrics & gynecology 2020; (59(4)):575-579 doi:10.1016/j.tjog.2020.05.018.

    PMID: 32653132
  16. 16

    "The threat of Asherman syndrome": a propensity score-matched study of fetal-maternal outcomes.

    Hanstede MMF, Veersema S, Emanuel MH, et al.

    Fertility and sterility 2025; (124(5 Pt 2)):1104-1114 doi:10.1016/j.fertnstert.2025.06.027.

    PMID: 40578664

This page provides an overview of Asherman syndrome for educational purposes only. Always consult a hysteroscopic specialist or reproductive endocrinologist for accurate diagnosis and personalized surgical treatment.

Get notified when new evidence is published on Asherman syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.